Two-year clinical outcome of all-comers treated with three highly dissimilar contemporary coronary drug-eluting stents in the randomised BIO-RESORT trial

EuroIntervention 2018;14:915-923 published online ahead of print May 2018. DOI: 10.4244/EIJ-D-18-00336

Marlies Kok
Marlies M. Kok1, MD; Paolo Zocca1, MD; Rosaly A. Buiten1, MD; Peter W. Danse2, MD, PhD; Carl E. Schotborgh3, MD; Martijn Scholte4, MD; Marc Hartmann1, MD, PhD; Martin G. Stoel1, MD, PhD; K. Gert van Houwelingen1, MD; Gerard C.M. Linssen5, MD, PhD; Carine J.M. Doggen6, PhD; Clemens von Birgelen1,6*, MD, PhD
1. Department of Cardiology, Thoraxcentrum Twente, Medisch Spectrum Twente, Enschede, the Netherlands; 2. Department of Cardiology, Rijnstate Hospital, Arnhem, the Netherlands; 3. Department of Cardiology, Haga Hospital, The Hague, the Netherlands; 4. Dep

Aims: The aim of the study was to evaluate the two-year clinical outcome of all-comer trial participants who were treated with two very different thin-strut biodegradable polymer versus t

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

clinical trialsclinical researchnstemistable anginastemi
Read next article
Non-invasive treatment planning of tandem coronary artery lesions using an interactive planner for PCI

Latest news